These findings indicated that PRMT5 deficiency in cervical cancer cells boosts T cell recruitment into the tumor microenvironment by enhancing CXCL10 secretion, resulting in a higher number of T cell infiltrations. This evidence concerns the gene PRMT5 and cervical cancer.